Therapeutics
We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for companion animals and livestock. Our dedicated Research teams work together with our human pharma colleagues, as well as with numerous external partners to identify, validate and bring new and innovative treatment pathways and modalities into our pipeline for development into game-changing veterinary medicines.
Related Press Releases

April 21, 2022
Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses

January 18, 2022